Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.
M Koutsilieris, … , H P Bennett, D Goltzman
M Koutsilieris, … , H P Bennett, D Goltzman
Published October 1, 1987
Citation Information: J Clin Invest. 1987;80(4):941-946. https://doi.org/10.1172/JCI113186.
View: Text | PDF
Research Article

Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.

  • Text
  • PDF
Abstract

We examined the characteristics of mitogens extracted from human benign prostatic hyperplasia and prostatic adenocarcinoma tissue. Although mitogens for fetal rat skin fibroblasts as well as for rat calvarial osteoblasts and osterosarcoma cells were found, distinct entities that acted selectively in cells of the osteoblast phenotype could be obtained by sequential reverse-phase high performance liquid chromatography. Two peptides with apparent molecular weights of 10,000 and 13,000 D were derived from hyperplastic tissue, whereas a single moiety of 10,000 D was obtained from malignant tissue. These entities increased cell numbers and alkaline phosphatase activity in osteoblastlike cells consistent with effects on both growth and differentiation. Prostatic peptides did not stimulate adenylate cyclase in osteosarcoma cells. Mitogenic activity selective for osteoblastlike cells was identified in postpubertal but not prepubertal normal prostate. The results demonstrate the existence of osteoblastic growth factors in prostatic tissue whose presence may accompany postpubertal development.

Authors

M Koutsilieris, S A Rabbani, H P Bennett, D Goltzman

×

Total citations by year

Year: 2022 2020 2018 2016 2015 2013 2010 2009 2008 2006 2005 2004 2003 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 Total
Citations: 1 1 1 1 2 3 1 3 6 2 2 1 4 3 2 4 3 6 3 2 7 7 5 6 3 4 2 85
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (85)

Title and authors Publication Year
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
He Y, Xu W, Xiao YT, Huang H, Gu D, Ren S
Signal Transduction and Targeted Therapy 2022
Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy
Q Fu, Z Yu
Life Sciences 2020
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
N Mahmood, C Mihalcioiu, SA Rabbani
Frontiers in Oncology 2018
Young patient with arterial thrombosis and skin changes as the onset manifestations: POEMS syndrome
T Han, S Zheng, Z Chen, W Liu, Y Hu
Oncotarget 2016
Oncogenic Role of the Ec Peptide of the IGF-1Ec Isoform in Prostate Cancer
A Armakolas, M Kaparelou, A Dimakakos, E Papageorgiou, N Armakolas, A Antonopoulos, C Petraki, M Lekarakou, P Lelovas, M Stathaki, C Psarros, I Donta, PS Galanos, P Msaouel, VG Gorgoulis, M Koutsilieris
Molecular Medicine 2015
Prospective Comparison of 99m Tc-MDP Scintigraphy, Combined 18 F-NaF and 18 F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer
R Minamimoto, A Loening, M Jamali, A Barkhodari, C Mosci, T Jackson, P Obara, V Taviani, SS Gambhir, S Vasanawala, A Iagaru
Journal of Nuclear Medicine 2015
Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer
P Msaouel, G Nandikolla, SG Pneumaticos, M Koutsilieris
Expert Opinion on Investigational Drugs 2013
Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer
A Philippou, A Armakolas, M Koutsilieris
Frontiers in Endocrinology 2013
Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications
SG Pneumaticos, A Christofides, E Gkioka, T Kalogeropoulos, P Msaouel, M Koutsilieris
Expert Opinion on Therapeutic Targets 2013
Expression of IGF-1Ec (MGF) transcript in human prostate cancer: evidence for a novel and autonomous growth factor activity of MGF E peptide in human PC-3 and LNCaP prostate cancer cells
Athanasios Armakolas, Anastassioss Philippou, Zacharoula Panteleakou, Adrew Nezos, Antigoni Sourla, Constantine Petraki, Michael Koutsilieris
The Prostate 2010
Expression of PGK1 by Prostate Cancer Cells Induces Bone Formation
Y Jung, Y Shiozawa, J Wang, J Wang, Z Wang, EA Pedersen, CH Lee, CL Hall, PJ Hogg, PH Krebsbach, ET Keller, RS Taichman
Molecular cancer research : MCR 2009
IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions in Rat Cardiomyocytes in Vitro
A Stavropoulou, A Halapas, A Sourla, A Philippou, E Papageorgiou, A Papalois, M Koutsilieris
Molecular Medicine 2009
Bone Metastases
D Kardamakis, V Vassiliou, E Chow
2009
Mechanisms of bone metastasis in prostate cancer: clinical implications
P Msaouel, N Pissimissis, A Halapas, M Koutsilieris
Best Practice & Research Clinical Endocrinology & Metabolism 2008
Orthopaedic bone cements
M Phillips, K Joshi
Orthopaedic bone cements 2008
Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells
E Papageorgiou, N Pitulis, M Manoussakis, P Lembessis, M Koutsilieris
Molecular Medicine 2008
The kisspeptin (KiSS-1)/GPR54 system in cancer biology
A Makri, N Pissimissis, P Lembessis, C Polychronakos, M Koutsilieris
Cancer Treatment Reviews 2008
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Characterization of Osteolytic, Osteoblastic, and Mixed Lesions in a Prostate Cancer Mouse Model Using 18 F-FDG and 18 F-Fluoride PET/CT
WK Hsu, MS Virk, BT Feeley, DB Stout, AF Chatziioannou, JR Lieberman
Journal of Nuclear Medicine 2008
Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach
M Koutsilieris, J Bogdanos, C Milathianakis, P Dimopoulos, T Dimopoulos, D Karamanolakis, A Halapas, R Tenta, H Katopodis, E Papageorgiou, N Pitulis, N Pissimissis, P Lembessis, A Sourla
Expert Opinion on Investigational Drugs 2006
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions
BT Feeley, L Krenek, N Liu, WK Hsu, SC Gamradt, EM Schwarz, J Huard, JR Lieberman
Bone 2006
Influence of BMPs on the Formation of Osteoblastic Lesions in Metastatic Prostate Cancer
BT Feeley, SC Gamradt, WK Hsu, N Liu, L Krenek, P Robbins, J Huard, JR Lieberman
Journal of Bone and Mineral Research 2005
Integration/Interaction of Oncologic Growth
GG Meadows
2005
The Biology of Skeletal Metastases
ET Keller, LW Chung
2004
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone
Y Lee, E Schwarz, M Davies, M Jo, J Gates, J Wu, X Zhang, JR Lieberman
Journal of Orthopaedic Research 2003
A Proteome Study of Secreted Prostatic Factors Affecting Osteoblastic Activity: Galectin-1 Is Involved in Differentiation of Human Bone Marrow Stromal Cells
H Andersen, ON Jensen, EP Moiseeva, EF Eriksen
Journal of Bone and Mineral Research 2003
A proteome study of secreted prostatic factors affecting osteoblastic activity: identification and characterisation of cyclophilin A
H Andersen, ON Jensen, EF Eriksen
European Journal of Cancer 2003
Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer
H Masuda, Y Fukabori, K Nakano, Y Takezawa, T cSuzuki, H Yamanaka
The Prostate 2003
Molecular biology and cellular physiology of refractoriness to androgen ablation therapy in advanced prostate cancer
M Koutsilieris, CS Mitsiades
Expert Opinion on Investigational Drugs 2001
Antalgic treatment of pain associated with bone metastases
C Reale, AM Turkiewicz, CA Reale
Critical Reviews in Oncology/Hematology 2001
ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line
N Juretic, JF Santib��ez, C Hurtado, J Mart�nez
Journal of Cellular Biochemistry 2001
Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption
JW Chiao, BS Moonga, YM Yang, R Kancherla, A Mittelman, JR Wu-Wong, T Ahmed
British Journal of Cancer 2000
Insulin-like Growth Factor I and Urokinase-type Plasminogen Activator Bioregulation System as a Survival Mechanism of Prostate Cancer Cells in Osteoblastic Metastases: Development of Anti-Survival Factor Therapy for Hormone-Refractory Prostate Cancer
M Koutsilieris, C Mitsiades, A Sourla
Molecular Medicine 2000
Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone-related protein
EA Blomme, KM Dougherty, KJ Pienta, CC Capen, TJ Rosol, LK McCauley
The Prostate 1999
Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: Case report
M Koutsilieris, M Tzanela, T Dimopoulos
The Prostate 1999
Thy-1 Antigen Expression by Cells in the Osteoblast Lineage
XD Chen, HY Qian, L Neff, K Satomura, MC Horowitz
Journal of Bone and Mineral Research 1999
The biology and management of bone metastases
TA Plunkett, RD Rubens
Critical Reviews in Oncology/Hematology 1999
Detection of an inhibiting activity for osteoclast bone resorption from human prostatic cancer cells
BS Moonga, JW Chiao
Cancer Letters 1998
Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis
C Reyes-Moreno, A Sourla, I Choki, C Doillon, M Koutsilieris
Urology 1998
Cancer and Bone*
TA Guise, GR Mundy
Endocrine reviews 1998
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
Bisphosphonates in prostate carcinoma
S Adami
Cancer 1997
Multiple myeloma associated with diffuse osteosclerotic bone lesions: A clinical entity distinct from osteosclerotic myeloma (POEMS syndrome)
MQ Lacy, MA Gertz, CA Hanson, DJ Inwards, RA Kyle
American Journal of Hematology 1997
Inhibition of osteoblastic cell differentiation by conditioned medium derived from the human prostatic cancer cell line PC-3 in vitro
J Kido, N Yamauchi, K Ohishi, M Kataoka, S Nishikawa, T Nakamura, H Kadono, D Ikedo, A Ueno, N Nonomura, A Okuyama, T Nagata
Journal of Cellular Biochemistry 1997
Malignant bone pain: pathophysiology and treatment
S Mercadante
PAIN 1997
Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton
C Reyes-Moreno, M Koutsilieris
Clinical & Experimental Metastasis 1997
Prostate-derived soluble factors block osteoblast differentiation in culture
J Martínez, S Silva, JF Santibáñez
Journal of Cellular Biochemistry 1996
Soluble factors produced by PC-3 prostate cells decrease collagen content and mineralisation rate in fetal rat osteoblasts in culture
JF Santibáñez, S Silva, J Martínez
British Journal of Cancer 1996
Tumor Biology
AS Tsiftsoglou, AC Sartorelli, DE Housman, TM Dexter
Tumor Biology 1996
Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts
A Sourla, M Koutsilieris
Journal of Clinical Investigation 1995
Skeletal metastases in advanced prostate cancer: cell biology and therapy
M Koutsilieris
Critical Reviews in Oncology/Hematology 1995
Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer
M Koutsilieris, A Sourla, G Pelletier, CJ Doillon
Journal of Bone and Mineral Research 1994
Prostate cancer progression. Implications of histopathology
JL Ware
The American Journal of Pathology 1994
Biochemical and Molecular Aspects of Selected Cancers
E Eigenbrodt, U Gerbracht, S Mazurek, P Presek, R Friis
Biochemical and Molecular Aspects of Selected Cancers 1994
Case Report: Clinical Hypocalcemia: The Endocrine Conference of the Alton Ochsner Medical Institutions and Tulane University-Medical Center
MC Wiegand, A Burshell, J Jaspan, AO Odugbesan
The American Journal of the Medical Sciences 1994
Membrane Physiopathology
G Bkaily
1994
Metastatic Bone Disease
IJ Diel, M Kaufmann, G Bastert
1994
Ultrastructure of the Male Urogenital Glands
A Riva, FT Riva, P Motta
1994
Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells
E Canalis, M Centrella, T McCarthy
Journal of Clinical Investigation 1993
Osteoclast inhibition for the treatment of bone metastases
RE Coleman, OP Purohit
Cancer Treatment Reviews 1993
The Effects of Orchidectomy on Skeletal Metabolism in Metastatic Prostate Cancer
NW Clarke, J McClure, NJ George
Scandinavian Journal of Urology and Nephrology 1993
Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells
E Canalis, M Centrella, T McCarthy
Journal of Clinical Investigation 1993
Histology of Ancient Human Bone: Methods and Diagnosis
G Grupe, AN Garland
1993
Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer
JL Ware
Cancer and Metastasis Reviews 1993
Physiology and Pharmacology of Bone
GR Mundy, TJ Martin
1993
Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia
H Bentley, FC Hamdy, KA Hart, JM Seid, JL Williams, D Johnstone, RG Russell
British Journal of Cancer 1992
Urokinase and the mechanism of osteoblastic metastases by prostate cancer
D Goltzman, I Bolivar, LA Moroz, SA Rabbani
Fibrinolysis 1992
Prostate Cancer and Bone Metastasis
JP Karr, H Yamanaka
1992
Control of Growth Factors and Prevention of Cancer
MB Sporn
1992
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase
SA Rabbani, AP Mazar, SM Bernier, M Haq, I Bolivar, J Henkin, D Goltzman
The Journal of biological chemistry 1992
Mechanisms of osteolytic bone destruction
GR Mundy
Bone 1991
Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: Characterization of the receptors involved
C Polychronakos, U Janthly, JG Lehoux, M Koutsilieris
The Prostate 1991
Serum and prostatic growth-promoting factors for steroid-independent epithelial cells of adult dog prostate
S Chevalier, G McKercher, A Chapdelaine
The Prostate 1991
Growth factors in the human prostate
G Fiorelli, AD Bellis, A Longo, P Pioli, A Constantini, S Giannini, G Forti, M Serio
The Journal of Steroid Biochemistry and Molecular Biology 1991
International Review of Cytology
RA Miller
International Review of Cytology 1991
Molecular and Cellular Biology of Prostate Cancer
JP Karr, DS Coffey, RG Smith, DJ Tindall
1991
Establishment of an osseous cell line from fetal rat calvaria using an immunocytolytic method of cell selection: Characterization of the cell line and of derived clones
SM Bernier, J Desjardins, AK Sullivan, D Goltzman
Journal of Cellular Physiology 1990
Production and significance of TGF-β in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma
Y Matuo, N Nishi, H Takasuka, Y Masuda, K Nishikawa, JT Isaacs, PS Adams, WL McKeehan, GH Sato
Biochemical and Biophysical Research Communications 1990
Hypocalcemia in cancer
EC Abramson, H Gajardo, SC Kukreja
Bone and Mineral 1990
Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis
M Hüfner, H Döhner, J Schmidt, P Möller, AD Ho, W Hunstein
Klinische Wochenschrift 1989
Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate
P Davies, CL Eaton
The Prostate 1989
Human uterus-derived growth substances for rat bone cells and fibroblasts
M Koutsilieris
American Journal of Obstetrics and Gynecology 1989
Hypercalcaemia of malignancy
PJ Kelly, JA Eisman
Cancer and Metastasis Reviews 1989
Hypocalcemia in patients with prostate cancer
SC Kukreja, A Shanmugam, TE Lad
Calcified Tissue International 1988
Application of octadecylsilyl-silica in purification studies related to the nontransformed rat ventral prostate androgen receptor
M Koutsilieris, F Bouthillier, F Grondin, F Radwan, M Carmel, M Elhilali, JG Lehoux
The Prostate 1988

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts